Nutritional composition comprising immunoglobulins and oligosaccharides
AssigneeN. V. Nutricia
InventorsGünther Boehm, Laura M'Rabet, Bernd Stahl, Johan Garssen, Antony William Scammell, Raymonde Peter Peeters
Life of this patent
Estimating the term…
Abstract
The present invention provides a method and composition for the treatment and/or prevention of infection, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and immunoglobulin from the milk or colostrum of hyperimmunized cows.
Claims9
A method of reducing the incidence of upper respiratory tract infection episodes comprising administering to an infant mammal in need thereof a liquid infant formula composition consisting of:
- (a) 0.5-10 grams transgalactooligosaccharide per 100 grams dry weight of the composition,
- (b) 0.5-10 grams fructopolysaccharide per 100 grams dry weight of the composition,
- (c) optionally, indigestible dextrins, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides, mannooligosaccharides, fucooligosaccharides, fructans, fructooligosaccharide, hydrolysed inulin, inulin or lactose, and
- (d) optionally, a long chain polyunsaturated fatty acid (LC-PUFA),
- wherein, as a percentage of the total caloric value of the composition, (i) 35-50% energy is derived from fat;
- (ii) 7.5-12.5% energy is derived from protein;
- and 40-55% energy is derived from carbohydrate;
- and
- wherein the composition is in the form of a liquid and does not comprise human milk.
A method of reducing the incidence of upper respiratory tract infection episodes comprising administering to an infant mammal in need thereof a liquid infant formula composition consisting of:
- (a) 0.5-10 grams transgalactooligosaccharide per 100 grams dry weight of the composition,
- (b) 0.5-10 grams fructopolysaccharide per 100 grams dry weight of the composition,
- (c) optionally, indigestible dextrins, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides, mannooligosaccharides, fucooligosaccharides, fructans, fructooligosaccharide, hydrolysed inulin or inulin, and
- (d) optionally, a long chain polyunsaturated fatty acid (LC-PUFA),
- wherein the composition is in the form of a liquid and does not comprise human milk.
Dependencies are inferred from the claim text.